Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study

OBJECTIVE: The aim of this retrospective study was to evaluate the efficacy and prognostic factors of bortezomib and dexamethasone (BD) chemotherapy regimen in the treatment of newly diagnosed multiple myeloma (MM) patients in our hospital. METHODS: A total of 47 newly diagnosed MM patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Runzhe, Zhang, Xiaoping, Gao, Chong, Luan, Chengxin, Wang, Yujie, Chen, Baoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576706/
https://www.ncbi.nlm.nih.gov/pubmed/28883741
http://dx.doi.org/10.2147/CMAR.S144405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576706/
https://www.ncbi.nlm.nih.gov/pubmed/28883741
http://dx.doi.org/10.2147/CMAR.S144405

Ejemplares similares